Genetically Proxied Glucose-lowering Drug Target and Risk of Immune Mediated Inflammatory Disease: A Mendelian Randomization Study

被引：0
|
作者：
Wu, Dongze [1 ]
Jin, Yingzhao [2 ]
机构：
[1] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Dept Rheumatol & Immunol, Chengdu, Peoples R China
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Peoples R China
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2049
引用
收藏
页码：4152 / 4154
页数：3
相关论文
共 50 条
  • [31] GENETICALLY PROXIED THERAPEUTIC INHIBITION OF ANTIHYPERTENSIVE DRUG TARGETS AND RISK OF SYSTEMIC LUPUS ERYTHEMATOSUS: A MENDELIAN RANDOMIZATION ANALYSIS
    Song, S.
    Wang, C.
    Zhao, R.
    Qiao, J.
    Zhang, S. X.
    Li, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1067 - 1067
  • [32] Genetically proxied appendicular lean mass and stroke risk: A two-step mendelian randomization study
    Li, Zhiming
    Liu, Xueyun
    Wen, Jianshang
    Wang, Zijie
    Xie, Yanfang
    Zhu, Lei
    Wu, Xiaosan
    Fang, Chuanqin
    Tian, Yanghua
    Li, Qi
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2024, 33 (10):
  • [33] Lipid Lowering and Alzheimer Disease Risk: A Mendelian Randomization Study
    Williams, Dylan M.
    Finan, Chris
    Schmidt, Amand F.
    Burgess, Stephen
    Hingorani, Aroon D.
    ANNALS OF NEUROLOGY, 2020, 87 (01) : 30 - 39
  • [34] Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study
    Lv, Xiaoshuo
    Gao, Xixi
    Liu, Jingwen
    Deng, Yisen
    Nie, Qiangqiang
    Fan, Xueqiang
    Ye, Zhidong
    Liu, Peng
    Wen, Jianyan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Associations between Genetically Proxied Inhibition of Lipid-Lowering Drug Targets and Serum Micronutrients among Individuals of European Descent: A Mendelian Randomization Study
    He, Jing-Yang
    Zhang, Xue
    Wang, Kui
    Lv, Wan-Qiang
    JOURNAL OF NUTRITION, 2022, 152 (05): : 1283 - 1290
  • [36] Association of Antidiabetic Drug Target Genes with Inflammatory Bowel Disease: A Mendelian Randomization Study
    Qing, Xiangli
    Wang, Lin
    Fang, Shuangshuang
    Ban, Yanran
    Zhong, Zhuotai
    Sun, Weiqi
    Zhang, Chenhui
    Zhang, Tao
    Yang, Yang
    Wei, Wei
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 1389 - 1396
  • [37] A drug target Mendelian randomization study of triglyceride lowering therapies for aortic stenosis
    Ciofani, Jonathan
    Han, Daniel
    Gill, Dipender
    Rao, Karan
    Allahwala, Usaid
    Bhindi, Ravinay
    CIRCULATION, 2024, 150
  • [38] Genetically proxied lean mass and risk of Alzheimer's disease: mendelian randomisation study
    Daghlas, Iyas
    Nassan, Malik
    Gill, Dipender
    BMJ MEDICINE, 2023, 2 (01):
  • [39] Lipid traits and lipid-lowering drug target genes and risk of melanoma: a mendelian randomization study
    Che, Yuhui
    Yuan, Jinyao
    Tang, Dadong
    Guo, Jing
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (06)
  • [40] Lipid-lowering drug targets associated with risk of respiratory disease: a Mendelian randomization study
    Gong, Zhipeng
    Wu, Dongsheng
    Ku, Yin
    Zou, Congyao
    Qiu, Lin
    Hao, Xiaohu
    Liu, Lunxu
    BMC PULMONARY MEDICINE, 2025, 25 (01):
12345